Mode
Text Size
Log in / Sign up

Descriptive analysis of extracellular particles in human biofluids from healthy participantsHidden particles in blood may protect the body

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider these preliminary descriptive findings as a resource for biofluid selection in future ex-Mito and cf-mtDNA studies.

This is a descriptive analysis of circulating particles in human biofluids from ten healthy participants (five females, five males, mean age 44.9 years). The study used electron microscopy to analyze particles from cf-mtDNA-enriched plasma (citrate, heparin, and EDTA), serum (red and gold top), and saliva.

The authors report that double-membrane extracellular particles consistent with mitochondrial ultrastructure were present across all tested biofluids, along with EVs and other particle types. They also note a positive association between plasma cf-mtDNA concentrations and the presence of double-membrane, ex-Mito-like particles, with individuals having higher cf-mtDNA concentrations tending to contain more of these particles.

Key limitations acknowledged by the authors include the preliminary nature of the results, the descriptive analysis without inferential statistics, the small sample size (n=10), and the inclusion of healthy participants only. Causation is not established, and the findings are not intended to infer clinical implications or generalize to diseased populations.

The authors suggest this work provides a resource to inform biofluid selection and technical considerations for future studies quantifying ex-Mito and cf-mtDNA. Practice relevance is limited to guiding methodological choices in subsequent research.

The body may be sending repair crews, not just alarm signals

These tiny powerhouses are wrapped in double membranes, just like they are inside cells. That means they’re not broken pieces. They’re packaged. Protected. Maybe on a mission.

Think of it like this. Imagine a factory with machines that sometimes break. Old thinking said when a machine shatters, the pieces scatter, causing chaos. But what if, instead, the factory sends out whole repair drones in protective pods? These pods travel to other factories, deliver tools, and help fix problems.

That’s what these extracellular mitochondria might be. Not trash. Messengers. Helpers.

Researchers looked at plasma, serum, and saliva from ten healthy adults. They used strong microscopes to see what’s really in our fluids. They found three main things: tiny bubbles called extracellular vesicles, loose particles, and double-membrane structures that look exactly like mitochondria.

They also measured how much cell-free mitochondrial DNA was in each sample. People with more of this DNA also had more of these intact-looking mitochondria particles. That suggests the DNA isn’t just floating loose. It’s packed inside something.

This changes how we think about what’s happening in the body. Instead of loose DNA causing trouble, we may be seeing a communication system. Mitochondria could be shipped from one cell to another. Maybe to boost energy. Maybe to warn of danger. Maybe to help heal.

This doesn’t mean this treatment is available yet.

The study only looked at healthy people. It was small. Just ten participants. But it opens a door. If mitochondria are being shared, could we use that to help patients? After heart attacks, sepsis, or chronic fatigue?

Doctors already measure mitochondrial DNA in some conditions. But now they may need to ask: Is it free-floating? Or is it inside a particle? That could change what the results mean.

One big surprise was finding these particles in saliva. That’s not a fluid we usually link to deep body processes. But if mitochondria are traveling there too, it could mean we can test for health signals without a blood draw.

But there's a catch. We don’t know where these mitochondria come from. Or where they’re going. Or how they’re made. Are they released on purpose? Do they get taken up by other cells? Can they actually work once they arrive?

Experts say this work adds weight to the idea of “mitochondrial transfer.” Some lab studies already show cells donating mitochondria to neighbors in distress. Now we have visual proof they’re in our fluids. That makes the idea much more real.

So what does this mean for you? Not much today. You can’t get tested for extracellular mitochondria. No doctor will change your treatment based on this yet. But it could shape future tests. Maybe one day, a simple saliva swab could tell us about your body’s stress levels or healing response.

The study has limits. Small size. Healthy volunteers only. No proof yet that these mitochondria are active or functional. They look intact. But are they alive? Can they make energy? We don’t know.

What happens next? Scientists will need to repeat this with more people. Then test those who are sick. They’ll need tools to tell the difference between damaged debris and healthy, shipped mitochondria. And they’ll need to track what these particles do in the body.

This is early science. But it shifts the story. From damage to dialogue. From noise to signal. The body may be talking in ways we’re only beginning to hear.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Human biofluids contain cell-free mitochondrial DNA (cf-mtDNA) and extracellular mitochondria (ex-Mito), creating the challenge of defining their origins, destinations, mechanisms of regulation, and purposes. To expand our understanding of cf-mtDNA biology, we present a descriptive electron microscopy analysis of circulating particles from cf-mtDNA-enriched plasma (citrate, heparin, and EDTA), serum (red and gold top), and saliva collected from ten healthy participants (5 females, 5 males, mean age 44.9 years). Ex-mito and extracellular vesicles (EVs) were isolated by centrifugation followed by size-exclusion chromatography, imaged by transmission electron microscopy, and morphometrically analyzed. In parallel, cf-mtDNA was quantified in each biofluid. The resulting catalog of the most common circulating particles in plasma, serum, and saliva show that circulating double-membrane extracellular particles-consistent with mitochondrial ultrastructure-are present across human biofluids, along with EVs and other particle types. Combining imaging with cf-mtDNA quantification, we show that individuals with higher plasma cf-mtDNA concentrations tend to contain more double-membrane, ex-Mito-like particles. These preliminary results challenge the notion that, under normal conditions, the majority of cf-mtDNA exists as naked and potentially pro-inflammatory forms. Instead, these results are consistent with the concept of mitochondria transfer and/or signaling between cells and tissues. The image inventory provided here expands our knowledge of cell-free mitochondrial biology and provides a resource to inform biofluid selection and technical considerations in future studies quantifying ex-Mito and cf-mtDNA.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.